NCT02569814View on ClinicalTrials.gov

A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin

PHASE1CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
HypertensionHyperlipidemia
Interventions
DRUG

Fimasartan/Amlodipine/Rosuvastatin

DRUG

Fimasartan/Amlodipine

DRUG

Rosuvastatin

Trial Locations (1)

Unknown

Inje University Busan Paik Hospital, Busan

Sponsors
All Listed Sponsors
lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY

NCT02569814 - A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin | Biotech Hunter | Biotech Hunter